Why Nostr? What is Njump?
2024-03-12 07:41:23

背包𝕏客 on Nostr: ...

近日,乐普生物宣布其自主研发的靶向组织因子(TF)的抗体偶联药物(ADC)产品MRG004A的申请获得美国FDA授予快速通道资格,用于治疗胰腺癌。 https://t.co/M0ec6x7PMh
Author Public Key
npub1prf94yejpguxmzntx49925ksmqyk904pglpa474v35v7vvrm05gq7605hy